CORD-19:775b90287b44353bee979abb0970a4666022f86d / 251582-251741 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T73069","span":{"begin":0,"end":159},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The second study was a double-blind randomized 1-year safety study of flunisolide HFA and placebo in children 4 to 9 years of age with mild-to-moderate asthma."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T218","span":{"begin":0,"end":159},"obj":"Sentence"}],"text":"The second study was a double-blind randomized 1-year safety study of flunisolide HFA and placebo in children 4 to 9 years of age with mild-to-moderate asthma."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1595","span":{"begin":82,"end":85},"obj":"Disease"},{"id":"T1596","span":{"begin":152,"end":158},"obj":"Disease"},{"id":"T13518","span":{"begin":82,"end":85},"obj":"Disease"},{"id":"T20840","span":{"begin":152,"end":158},"obj":"Disease"}],"attributes":[{"id":"A1595","pred":"mondo_id","subj":"T1595","obj":"http://purl.obolibrary.org/obo/MONDO_0007710"},{"id":"A1596","pred":"mondo_id","subj":"T1596","obj":"http://purl.obolibrary.org/obo/MONDO_0004979"},{"id":"A51534","pred":"mondo_id","subj":"T13518","obj":"http://purl.obolibrary.org/obo/MONDO_0007710"},{"id":"A82462","pred":"mondo_id","subj":"T20840","obj":"http://purl.obolibrary.org/obo/MONDO_0004979"}],"text":"The second study was a double-blind randomized 1-year safety study of flunisolide HFA and placebo in children 4 to 9 years of age with mild-to-moderate asthma."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T1094","span":{"begin":152,"end":158},"obj":"Phenotype"}],"attributes":[{"id":"A1094","pred":"hp_id","subj":"T1094","obj":"http://purl.obolibrary.org/obo/HP_0002099"}],"text":"The second study was a double-blind randomized 1-year safety study of flunisolide HFA and placebo in children 4 to 9 years of age with mild-to-moderate asthma."}